About Nima Farzan
Nima Farzan is a president and CEO, director at Latigo Biotherapeutics.
Nima Farzan reports to the SEC as a director or officer of 3 public companies, including Keros Therapeutics (KROS) and Kinnate Biopharma (KNTE).
Nima Farzan first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Nima Farzan in the role, so the role may have started earlier or lasted longer.
KI
Keros Therapeutics, Inc.
Director
2020 – 2026 · Public company (KROS)
KI
Kinnate Biopharma Inc.
Chief Executive Officer and director
2020 – 2024 · Public company (KNTE)
Key Colleagues at Startups
The people Nima Farzan works with at each company, as listed on that company's latest Form D.
Latigo Biotherapeutics, Inc. · Form D, Feb 13, 2025
NS
Nancy Stagliano
Director
BS
Beth Seidenberg
Director
JT
Jim Tananbaum
Director
DP
Deborah Palestrant
Director
KR
Kevin Raidy
Director
TL
Tim Lugo
Chief Financial Officer
TW
Tim Walbert
Director